LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕
    06/10/2021
    06/10/2021

    #EFIB2021: Industrial Biotechnology in the business spotlight for EU Green Deal

    Do you like it?
    Read more
    04/10/2021
    04/10/2021

    EuropaBio Comments on the Roadmap on Restoring Sustainable Carbon Cycles

    Do you like it?
    Read more
    30/09/2021
    30/09/2021

    Artificial intelligence: investing in new technologies in healthcare

    What if machine learning and artificial intelligence could learn to detect one of the most common forms of blood cancer, through evaluating data based on the gene activity of blood cells?
    Do you like it?
    Read more
    27/09/2021
    27/09/2021

    Europe celebrates life science with European Biotech Week 2021

    Do you like it?
    Read more
    08/09/2021
    08/09/2021

    Treatment Without Borders: The EU Case for Equitable Patient Access to Advanced Therapies

    Do you like it?
    Read more
    27/08/2021
    27/08/2021

    EuropaBio response to the Public consultation on European bioeconomy policy: stocktaking and future developments

    EuropaBio comments on the public consultation on blue bioeconomy.
    Do you like it?
    Read more
    10/08/2021
    10/08/2021

    EuropaBio comments on the public consultation on blue bioeconomy

    EuropaBio comments on the public consultation on blue bioeconomy.
    Do you like it?
    Read more
    02/08/2021
    02/08/2021

    EuropaBio response to the European Commission Public Consultation on the Regulations for Orphan Medicinal Products and Paediatrics

    EuropaBio has responded to the European Commission’s public consultation on the Orphan Medicinal Products (OMPs) and Paediatrics Regulations.
    Do you like it?
    Read more
    29/07/2021
    29/07/2021

    EuropaBio response to the Public Consultation ‘Digital Health Data and Services – The European Health Data Space’

    Do you like it?
    Read more
    26/07/2021
    26/07/2021

    EuropaBio response to the European Commission Public Consultation on the Regulation for Orphan Medicinal Products and Paediatrics: the value brought by the technology to patients and society should be well recognised

    Do you like it?
    Read more
    22/07/2021
    22/07/2021

    Call for tender: EuropaBio requires Maintenance and Development Services for its four Websites

    Do you like it?
    Read more
    20/07/2021
    20/07/2021

    EuropaBio’s response to the EC consultation on patients’ rights in cross-border healthcare

    Do you like it?
    Read more
    03/07/2021
    03/07/2021

    EuropaBio Members nominate Europe’s biotechnology landmarks from the last 25 years

    We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
    Do you like it?
    Read more
    29/06/2021
    29/06/2021

    A Declaration from Members of the World’s Biotechnology Sector On Global Access to COVID Vaccines & Treatments and the Role of Intellectual Property

    We, the undersigned CEOs of global biotechnology companies and associations have a social responsibility to work with other stakeholders to ensure that COVID vaccines and treatments get to the patients in the world who most need them.
    Do you like it?
    Read more
    29/06/2021
    29/06/2021

    EV Biotech joins EuropaBio: effective, bio-based alternatives to conventional chemical-synthetic production processes

    EuropaBio is pleased to announce that EV Biotech has joined the organization as an Associate Member.
    Do you like it?
    Read more
    23/06/2021
    23/06/2021

    Interview with… Dr. Jernej Pintar, CEO and Head of Tech Community at Technology Park Ljubljana

    EuropaBio sat down with new Member Technology Park Ljubljana, to find out about their journey from creation in 1994.
    Do you like it?
    Read more
    23/06/2021
    23/06/2021

    Technology Park Ljubljana joins EuropaBio: better world through better technology

    EuropaBio is pleased to announce that Technology Park Ljubljana has joined the organization as part of the National Associations Council.
    Do you like it?
    Read more
    16/06/2021
    16/06/2021

    EPSCO Council conclusions: EuropaBio calls for more pragmatic approach addressing access, availability and affordability of medicines

    Do you like it?
    Read more
    14/06/2021
    14/06/2021

    European Biotech Week 2021: EuropaBio invites national biotech communities to celebrate science and innovation

    Do you like it?
    Read more
    14/06/2021
    14/06/2021

    Novartis is proud to support the EuropaBio 25th Anniversary

    EuropaBio is delighted to announce that Novartis has joined EuropaBio’s 25th Anniversary Celebration Programme as a Sponsor.
    Do you like it?
    Read more
    Load more
    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.